@pstudenic.bsky.social
Rheumatologist | clinical Researcher | Vienna | collaborative | inflammatory arthritis | curiosities | @Stiddyo
🔬 Difficult-to-treat
When options run out, what works?
🎥 @GolnazShams and I discuss our SLR on therapies / options for D2T #RA patients and how @strata-fit.bsky.social is advancing personalized rheumatology care: youtu.be/na1sSPyX82w
#RheumatoidArthritis #DifficultToTreatRA #PersonalisedMedicine
When options run out, what works?
🎥 @GolnazShams and I discuss our SLR on therapies / options for D2T #RA patients and how @strata-fit.bsky.social is advancing personalized rheumatology care: youtu.be/na1sSPyX82w
#RheumatoidArthritis #DifficultToTreatRA #PersonalisedMedicine
Flash Science in Rheumatology, Episode 6: Therapeutic approaches for difficult-to-treat RA
YouTube video by Division of Rheumatology - MUW Vienna
youtu.be
August 24, 2026 at 7:57 PM
🔬 Difficult-to-treat
When options run out, what works?
🎥 @GolnazShams and I discuss our SLR on therapies / options for D2T #RA patients and how @strata-fit.bsky.social is advancing personalized rheumatology care: youtu.be/na1sSPyX82w
#RheumatoidArthritis #DifficultToTreatRA #PersonalisedMedicine
When options run out, what works?
🎥 @GolnazShams and I discuss our SLR on therapies / options for D2T #RA patients and how @strata-fit.bsky.social is advancing personalized rheumatology care: youtu.be/na1sSPyX82w
#RheumatoidArthritis #DifficultToTreatRA #PersonalisedMedicine
Reposted
Still wondering what SQUEEZE does? Learn more about our work in this @ec.europa.eu Horizon Magazine article: projects.research-and-innovation.ec.europa.eu/en/horizon-m... Intrigued? Come visit us at booth 📍O17 in the NPO section of #EULAR2026.
Squeezing more from arthritis drugs to help patients live better
Over the past two decades, a wave of new drug treatments for rheumatoid arthritis (RA) has allowed many people to live free from pain, joint swelling and long-term disability. But for many patients in...
projects.research-and-innovation.ec.europa.eu
June 4, 2026 at 5:38 AM
Still wondering what SQUEEZE does? Learn more about our work in this @ec.europa.eu Horizon Magazine article: projects.research-and-innovation.ec.europa.eu/en/horizon-m... Intrigued? Come visit us at booth 📍O17 in the NPO section of #EULAR2026.
Reposted
Golnaz Shams has been selected for a poster presentation @eular.org Congress (3-6 June in London).
The topic will be Clinical management strategies for difficult-to-treat rheumatoid arthritis.
You can find the abstract and more information in the comments.
@meduniwien.ac.at
The topic will be Clinical management strategies for difficult-to-treat rheumatoid arthritis.
You can find the abstract and more information in the comments.
@meduniwien.ac.at
May 27, 2026 at 1:54 PM
Golnaz Shams has been selected for a poster presentation @eular.org Congress (3-6 June in London).
The topic will be Clinical management strategies for difficult-to-treat rheumatoid arthritis.
You can find the abstract and more information in the comments.
@meduniwien.ac.at
The topic will be Clinical management strategies for difficult-to-treat rheumatoid arthritis.
You can find the abstract and more information in the comments.
@meduniwien.ac.at
Reposted
🎉 Meet the brilliant ARD & ERO Guest Social Media Editors for #EULAR2026! 🚀
Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.
Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.
June 2, 2026 at 9:53 PM
🎉 Meet the brilliant ARD & ERO Guest Social Media Editors for #EULAR2026! 🚀
Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.
Say hello to Jelena, Ertuğrul, Mariana, Guillermo, Rúben, Daliya, & Elvis! They’ll be bringing you the best insights straight from the congress.
Die @oegrr erweitert ihre Kommunikationsbandbreite💢
#Podcasts zu einer Vielfalt von #Rheuma Themen werden für alle Interessierte über den Herbst hinweg gelaunched!
Spannend für #Patientinnen sowie Gesundheitspersonal
#Podcasts zu einer Vielfalt von #Rheuma Themen werden für alle Interessierte über den Herbst hinweg gelaunched!
Spannend für #Patientinnen sowie Gesundheitspersonal
September 29, 2025 at 8:56 PM
Die @oegrr erweitert ihre Kommunikationsbandbreite💢
#Podcasts zu einer Vielfalt von #Rheuma Themen werden für alle Interessierte über den Herbst hinweg gelaunched!
Spannend für #Patientinnen sowie Gesundheitspersonal
#Podcasts zu einer Vielfalt von #Rheuma Themen werden für alle Interessierte über den Herbst hinweg gelaunched!
Spannend für #Patientinnen sowie Gesundheitspersonal
Reposted
Wir sind da! 🙂 🦴🩺
Folge uns um am Laufenden zu bleiben: Veranstaltungen, Deadlines🔬, Podcasts🎙️, Fortbildungen🩻und noch viel mehr!
Folge uns um am Laufenden zu bleiben: Veranstaltungen, Deadlines🔬, Podcasts🎙️, Fortbildungen🩻und noch viel mehr!
September 14, 2025 at 1:41 PM
Wir sind da! 🙂 🦴🩺
Folge uns um am Laufenden zu bleiben: Veranstaltungen, Deadlines🔬, Podcasts🎙️, Fortbildungen🩻und noch viel mehr!
Folge uns um am Laufenden zu bleiben: Veranstaltungen, Deadlines🔬, Podcasts🎙️, Fortbildungen🩻und noch viel mehr!
Super happy and proud about the publication of the first authored paper of my #PhD student Nasim Nakhost Lotfi in RMD Open 😊👏🎈
How reliable can we utilise different #PROMs in #apps when assessed in different frequencies?
Have a look 👇
rmdopen.bmj.com/cgi/content/...
#Rheum
#ehealth
#arthritis
How reliable can we utilise different #PROMs in #apps when assessed in different frequencies?
Have a look 👇
rmdopen.bmj.com/cgi/content/...
#Rheum
#ehealth
#arthritis
July 2, 2025 at 5:50 PM
Super happy and proud about the publication of the first authored paper of my #PhD student Nasim Nakhost Lotfi in RMD Open 😊👏🎈
How reliable can we utilise different #PROMs in #apps when assessed in different frequencies?
Have a look 👇
rmdopen.bmj.com/cgi/content/...
#Rheum
#ehealth
#arthritis
How reliable can we utilise different #PROMs in #apps when assessed in different frequencies?
Have a look 👇
rmdopen.bmj.com/cgi/content/...
#Rheum
#ehealth
#arthritis
@mdr-ra-project.bsky.social GA has brought together our consortium in the heat of #Verona
These 2 days enabled clarity on setting the tracks to achieve our goals
Endotypes of #D2T #RA
Development of a clever #CDSS
😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social
These 2 days enabled clarity on setting the tracks to achieve our goals
Endotypes of #D2T #RA
Development of a clever #CDSS
😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social
July 1, 2025 at 3:52 PM
@mdr-ra-project.bsky.social GA has brought together our consortium in the heat of #Verona
These 2 days enabled clarity on setting the tracks to achieve our goals
Endotypes of #D2T #RA
Development of a clever #CDSS
😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social
These 2 days enabled clarity on setting the tracks to achieve our goals
Endotypes of #D2T #RA
Development of a clever #CDSS
😊 to co-lead the clinical deep phenotyping together with @drpetermandl.bsky.social
2 weeks ago #EULAR2025 closed. A congress full of education and innovation spread over 4 days.
Project Meetings (#Squeeze #Stratafit
EULAR Meetings (qoc #bigdata #atrisk)
2 lectures on #AIforIA & #PRPinvolvement
together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks
Project Meetings (#Squeeze #Stratafit
EULAR Meetings (qoc #bigdata #atrisk)
2 lectures on #AIforIA & #PRPinvolvement
together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks
June 28, 2025 at 9:44 PM
2 weeks ago #EULAR2025 closed. A congress full of education and innovation spread over 4 days.
Project Meetings (#Squeeze #Stratafit
EULAR Meetings (qoc #bigdata #atrisk)
2 lectures on #AIforIA & #PRPinvolvement
together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks
Project Meetings (#Squeeze #Stratafit
EULAR Meetings (qoc #bigdata #atrisk)
2 lectures on #AIforIA & #PRPinvolvement
together with many conversations / exchanges and smiles filled my congress. ❤️ Thanks
Reposted
Christina Wettengl delivered an excellent oral presentation on the #ContextualAnalysis for the Care Model development in Switzerland for @squeezeproject.bsky.social #EULAR2025
June 12, 2025 at 9:18 AM
Christina Wettengl delivered an excellent oral presentation on the #ContextualAnalysis for the Care Model development in Switzerland for @squeezeproject.bsky.social #EULAR2025
#EULAR2025 also offered the possibilty to come together for scientific project meetings.
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas
June 14, 2025 at 9:08 PM
#EULAR2025 also offered the possibilty to come together for scientific project meetings.
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas
The @squeezeproject.bsky.social
Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas
One of the most crucial sessions for research in #rheumatology just started:
How to involve patients in your #research
💢Get your insights in #collaborativeresearch now
🤝
#EULAR2025
#PRP
How to involve patients in your #research
💢Get your insights in #collaborativeresearch now
🤝
#EULAR2025
#PRP
June 14, 2025 at 10:07 AM
One of the most crucial sessions for research in #rheumatology just started:
How to involve patients in your #research
💢Get your insights in #collaborativeresearch now
🤝
#EULAR2025
#PRP
How to involve patients in your #research
💢Get your insights in #collaborativeresearch now
🤝
#EULAR2025
#PRP
Reposted
Fantastic to see Sladjana, a STRATA-FIT patient research partner, presenting about the project and the evaluation of PRP involvement - partnership, communication, and support are critical #eular2025
June 13, 2025 at 8:49 AM
Fantastic to see Sladjana, a STRATA-FIT patient research partner, presenting about the project and the evaluation of PRP involvement - partnership, communication, and support are critical #eular2025
Reposted
Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV
June 12, 2025 at 2:41 PM
Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV
Very intense phenotyping of patients with RA in Remission double checked with #US comparing people tapering & stopping DMARD treatment with those continuing for the occurrence of #flare.
#spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025
#spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025
June 11, 2025 at 1:16 PM
Very intense phenotyping of patients with RA in Remission double checked with #US comparing people tapering & stopping DMARD treatment with those continuing for the occurrence of #flare.
#spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025
#spatialtranscriptomics #RNAseq #synovialbiopsy by Stefano Alivernini #EULAR2025
Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348
@squeezeproject.bsky.social
#EULAR2025
@squeezeproject.bsky.social
#EULAR2025
June 11, 2025 at 1:00 PM
Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348
@squeezeproject.bsky.social
#EULAR2025
@squeezeproject.bsky.social
#EULAR2025
Reposted
ICYMI, the inspiration for our April cover—Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial bit.ly/3GpCl9X
Plus linked Comment bit.ly/4ivhVKo
#Medsky #Rheumsky
Plus linked Comment bit.ly/4ivhVKo
#Medsky #Rheumsky
April 17, 2025 at 10:01 AM
ICYMI, the inspiration for our April cover—Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial bit.ly/3GpCl9X
Plus linked Comment bit.ly/4ivhVKo
#Medsky #Rheumsky
Plus linked Comment bit.ly/4ivhVKo
#Medsky #Rheumsky
Thank you @gregorbond.bsky.social for enriching the frame of biomarkers in the field of #rheumatoidarthritis.
#TTV as biomarker of immunosuppression has for sure different facets.
I always enjoy the #interdisciplinary exchange
#TTV as biomarker of immunosuppression has for sure different facets.
I always enjoy the #interdisciplinary exchange
Our coordinator @gregorbond.bsky.social today, presenting results of TTV-guided monitoring at the @squeezeproject.bsky.social General Assembly meeting, supporting SQUEEZE leader of Functional Drug Monitoring, @pstudenic.bsky.social, with spreading the Torque Teno virus to #Rheumatology. #TTVguide
April 16, 2025 at 8:11 PM
Thank you @gregorbond.bsky.social for enriching the frame of biomarkers in the field of #rheumatoidarthritis.
#TTV as biomarker of immunosuppression has for sure different facets.
I always enjoy the #interdisciplinary exchange
#TTV as biomarker of immunosuppression has for sure different facets.
I always enjoy the #interdisciplinary exchange
The last two days were dedicated to intense discussions, phrasing Update recommendations for large vessel #vasculitis
- #LVV -
Combining expertise from 15 countries
Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti
- #LVV -
Combining expertise from 15 countries
Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti
April 5, 2025 at 8:18 AM
The last two days were dedicated to intense discussions, phrasing Update recommendations for large vessel #vasculitis
- #LVV -
Combining expertise from 15 countries
Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti
- #LVV -
Combining expertise from 15 countries
Thanks to the leads C. Mukhtyar, B. Hellmich & E. Nikiphorou & the marvelous fellows @drminidey.bsky.social D. Misra A. Bartoletti
#Digitalrheumatology days update
#RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety
CBT was integrated into a 90 days program delivered via a smartphone app.
Promising results presented by @johannesknitza 👇
#RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety
CBT was integrated into a 90 days program delivered via a smartphone app.
Promising results presented by @johannesknitza 👇
March 22, 2025 at 9:54 AM
#Digitalrheumatology days update
#RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety
CBT was integrated into a 90 days program delivered via a smartphone app.
Promising results presented by @johannesknitza 👇
#RCT including people with inflammatory #arthritis and #SLE subjecting to either #CBT or leaflet information about #depression and anxiety
CBT was integrated into a 90 days program delivered via a smartphone app.
Promising results presented by @johannesknitza 👇
These days the #Digital #Rheumatology days are on again in #Berlin. #7th Edition
An interdisciplinary audience from 19 countries come together. 🌐
I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth
New insights and productive exchange 💢
An interdisciplinary audience from 19 countries come together. 🌐
I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth
New insights and productive exchange 💢
March 22, 2025 at 8:34 AM
These days the #Digital #Rheumatology days are on again in #Berlin. #7th Edition
An interdisciplinary audience from 19 countries come together. 🌐
I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth
New insights and productive exchange 💢
An interdisciplinary audience from 19 countries come together. 🌐
I had the pleasure to provide an update of developments over the past year in #digitalhealth #ehealth
New insights and productive exchange 💢
Reposted
Say hello to Europe's six new new AI Factories:
🇦🇹 AI:AT
🇧🇬 BRAIN++
🇫🇷 AI2F
🇩🇪 JAIF
🇵🇱 PIAST
🇸🇮 SLAIF
These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓
europa.eu/!F6KGPG
🇦🇹 AI:AT
🇧🇬 BRAIN++
🇫🇷 AI2F
🇩🇪 JAIF
🇵🇱 PIAST
🇸🇮 SLAIF
These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓
europa.eu/!F6KGPG
March 13, 2025 at 1:24 PM
Say hello to Europe's six new new AI Factories:
🇦🇹 AI:AT
🇧🇬 BRAIN++
🇫🇷 AI2F
🇩🇪 JAIF
🇵🇱 PIAST
🇸🇮 SLAIF
These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓
europa.eu/!F6KGPG
🇦🇹 AI:AT
🇧🇬 BRAIN++
🇫🇷 AI2F
🇩🇪 JAIF
🇵🇱 PIAST
🇸🇮 SLAIF
These factories will help startup, small and medium companies develop AI models using top supercomputing power, data, and talent ↓
europa.eu/!F6KGPG
Reposted
Cross-sectional study in the VA rheumatoid arthritis registry identified 8 peripheral blood biomarkers that could improve RA-interstitial lung disease risk stratification beyond clinical risk factors
In A&R
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#Medsky #Pulmsky
In A&R
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#Medsky #Pulmsky
March 11, 2025 at 12:41 PM
Cross-sectional study in the VA rheumatoid arthritis registry identified 8 peripheral blood biomarkers that could improve RA-interstitial lung disease risk stratification beyond clinical risk factors
In A&R
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#Medsky #Pulmsky
In A&R
acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
#Medsky #Pulmsky
International women's day
8th of March
developments in steps
Studying #medicine for women in Vienna was possible only since the start of the 20th century
Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades
8th of March
developments in steps
Studying #medicine for women in Vienna was possible only since the start of the 20th century
Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades
March 8, 2025 at 9:45 PM
International women's day
8th of March
developments in steps
Studying #medicine for women in Vienna was possible only since the start of the 20th century
Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades
8th of March
developments in steps
Studying #medicine for women in Vienna was possible only since the start of the 20th century
Dr. Anna Fischer-Dückelmann underwent med school in switzerland before publishing the book 👇 a novelty back then and reprinted over decades
Reposted
Bayesian meta-analysis of RCTs compared efficacy and safety of JAK inhibitors vs bDMARDs for nonsystemic forms of juvenile idiopathic arthritis. Results showed no significant difference in efficacy and safety outcomes among the treatment options
In ACROR
doi.org/10.1002/acr2...
#Medsky
In ACROR
doi.org/10.1002/acr2...
#Medsky
February 21, 2025 at 2:02 PM
Bayesian meta-analysis of RCTs compared efficacy and safety of JAK inhibitors vs bDMARDs for nonsystemic forms of juvenile idiopathic arthritis. Results showed no significant difference in efficacy and safety outcomes among the treatment options
In ACROR
doi.org/10.1002/acr2...
#Medsky
In ACROR
doi.org/10.1002/acr2...
#Medsky